Alan Bryce discusses PT-112, a platinum-containing drug with immunogenic cell death mechanism and osteotropic properties, with Oliver Sartor. The phase-two dose-finding study enrolled heavily ...
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
Comparing GreenLight PVP and HoLEP Beyond 5 Years: A Systematic Review of Long-Term Functional Outcomes and Reoperation Rates - Beyond the Abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback